Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Amnor Group is a Canadian pharmaceutical company headquartered in Boucherville, Quebec, specializing in the development, licensing, and distribution of generic and specialty pharmaceutical products. The company focuses on providing high-quality, affordable therapeutic options to the Canadian healthcare market, with a portfolio that spans cardiovascular health, metabolic disorders, and central nervous system treatments. Amnor operates through a strategic business model that leverages partnerships for manufacturing and supply chain management to ensure the consistent availability of essential medicines. Their product line primarily consists of oral solid dosage forms designed to meet stringent Health Canada regulatory standards. By focusing on value-added generics and efficient commercialization, Amnor Group serves as a key provider of cost-effective alternatives to brand-name medications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Amnor Group.